Legac E Author
Subjects of specialization
Affiliation
spinal interventions,, Infections
Biopathology Department, Regional Hospital Center Of Orleans, France
Legac ELegac Biopathology Department, Regional Hospital Center Of Orleans, France Chronic hepatitis C; Paroxysmal Nocturnal Hemoglobinuria; Eculizumab from the research gate a humanized monoclonal antibody, has brought a paradigm shift in PNH management and prognosis.
Case Report Open Access
Author(s): Chakkor A, Arar A,Sanciu R,Legac E,Cacoub P and Ahmed SNS
Hepatitis C virus (HCV) infection is a major health problem worldwide. It is a well-documented systemic disease whose extra hepatic consequences increase the weight of its pathological burden. Paroxysmal nocturnal hemoglobinuria (PNH) is a rare but life-threatening bone marrow failure disorder that manifests with hemolytic anemia, thrombosis and peripheral blood cytopenia. Fortunately, the introduction of Eculizumab, a humanized monoclonal antibody, has brought a paradigm shift in PNH management and prognosis. We hereby report an unusual association of HCV and PNH which has witnessed persistent breakthrough hemolysis and progression to complications despite Eculizumab. Our report suggests reconsidering the management of PNH patients with HCV especially since the only approved PNH treatm... view moreĀ»